Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'AML-TYPE CHEMOTHERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 7 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Beran, M; Shen, Y; Kantarjian, H; O'Brien, S; Koller, CA; Giles, FJ; Cortes, J; Thomas, DA; Faderl, S; Despa, S; Estey, EH
      High-dose chemotherapy in high-risk myelodysplastic syndrome - Covariate-adjusted comparison of five regimens

      CANCER
    2. Beran, M
      Intensive chemotherapy for patients with high-risk myelodysplastic syndrome

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    3. Bennett, JM; Flandrin, G; Matutes, E; Bloomfield, CD; Head, D; Pierre, R; Brunning, RD; Imbert, M; Vardiman, J
      Problematic WHO reclassification of myelodysplastic syndromes - Reply

      JOURNAL OF CLINICAL ONCOLOGY
    4. Beran, M; Estey, E; O'Brien, S; Cortes, J; Koller, CA; Giles, FJ; Kornblau, S; Andreeff, M; Vey, N; Pierce, SR; Hayes, K; Wong, GC; Keating, M; Kantarjian, H
      Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    5. Beran, M; Kantarjian, H
      Results of topotecan-based combination therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

      SEMINARS IN HEMATOLOGY
    6. ESTEY EH
      PROGNOSIS AND THERAPY OF SECONDARY MYELODYSPLASTIC SYNDROMES

      Haematologica
    7. ESTEY EH; KANTARJIAN HM; OBRIEN S; KORNBLAU S; ANDREEFF M; BERAN M; PIERCE S; KEATING M
      HIGH REMISSION RATE, SHORT REMISSION DURATION IN PATIENTS WITH REFRACTORY-ANEMIA WITH EXCESS BLASTS (RAEB) IN TRANSFORMATION (RAEB-T) GIVENACUTE MYELOGENOUS LEUKEMIA (AML)-TYPE CHEMOTHERAPY IN COMBINATION WITH GRANULOCYTE-CSF (G-CSF)

      Cytokines and molecular therapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 17:27:02